CJC-1295-DAC
Also known as: CJC-1295 with DAC, Drug Affinity Complex
Overview
A modified growth hormone-releasing hormone (GHRH) analog with an added Drug Affinity Complex (DAC) that extends its half-life. This allows for less frequent dosing compared to standard CJC-1295.
Benefits
- ✓growth hormone optimization
- ✓body composition
- ✓recovery enhancement
- ✓anti-aging effects
Potential Side Effects
- •injection site reactions
- •headache
- •flushing
- •dizziness
- •fatigue
- •water retention
Who Should Avoid
- ⚠pregnancy or breastfeeding
- ⚠active malignancy or cancer history
- ⚠diabetic retinopathy
- ⚠severe illness or post-surgical recovery
- ⚠hypersensitivity to components
Interactions & Precautions
May affect glucose metabolism and insulin sensitivity. Can interact with diabetes medications, thyroid medications, and corticosteroids. Comprehensive medication review with clinician required.
Dosing Information from Literature
Research protocols have used doses ranging from 0.5-2 mg administered once or twice weekly due to extended half-life from DAC modification.
This is descriptive information only. Always consult a licensed healthcare provider for dosing guidance.
Storage
Store unreconstituted peptide in freezer (-20°C or colder). After reconstitution with bacteriostatic water, store refrigerated and use within 2-3 weeks.